GlassScriptPhysician profile
Roy J Meckler
NPI 1578543344
$4,991.16
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,809 · 2020: $642 · 2021: $1,245 · 2022: $295.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $851.59 | 2019-2022 | |
| Biogen, INC. | $751.32 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $394.12 | 2019-2022 | |
| Emd Serono, INC. | $345.56 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $334.56 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $282.09 | 2021-2022 | |
| Ucb, INC. | $254.46 | 2019-2021 | |
| Genentech USA, INC. | $238.95 | 2019-2022 | |
| Acorda Therapeutics, INC | $153.79 | 2019-2021 | |
| Allergan, INC. | $151.05 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $131.08 | 2021 | |
| Mallinckrodt Enterprises LLC | $127.89 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $125.14 | 2019 | |
| Genzyme Corporation | $123.76 | 2019 | |
| Lilly USA, LLC | $104.22 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $96.89 | 2021 | |
| Alexion Pharmaceuticals, INC. | $81.72 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $68.77 | 2019-2021 | |
| Neurocrine Biosciences, INC. | $51.09 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $49.08 | 2020-2021 | |
| Abbvie INC. | $45.16 | 2019-2022 | |
| Supernus Pharmaceuticals, INC. | $36.39 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.32 | 2021 | |
| Jazz Pharmaceuticals INC. | $28.34 | 2020 | |
| Lundbeck LLC | $26.71 | 2019 | |
| Mdd US Operations, LLC | $19.87 | 2019 | |
| Merz North America, INC. | $17.95 | 2020 | |
| Assertio Therapeutics, INC. | $14.68 | 2020 | |
| Adamas Pharmaceuticals, INC. | $14.66 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.30 | 2021 | |
| Endo Pharmaceuticals INC. | $14.12 | 2019 | |
| Amneal Pharmaceuticals LLC | $11.53 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Meckler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.